Dr. David Sneid, MD (he/him) is an Endocrinologist in Kansas city, MO with over 18 years of experience. What is your opinion of Dr. David Sneid, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. David Sneid, MD has received over $3,971 which includes payments from the following companies:
$2,430.00 from GlaxoSmithKline, LLC.
$372.74 from LILLY USA, LLC
$235.86 from sanofi-aventis U.S. LLC
$215.00 from GENZYME CORPORATION
$198.54 from AstraZeneca Pharmaceuticals LP
$149.67 from AbbVie, Inc.
$74.77 from Salix Pharmaceuticals, Ltd
$66.08 from Janssen Pharmaceuticals, Inc
$50.07 from Auxilium Pharmaceuticals, Inc.
$35.57 from Boehringer Ingelheim Pharmaceuticals, Inc.
$34.22 from Takeda Pharmaceuticals America, Inc.
$26.35 from Amgen Inc.
$22.10 from Novo Nordisk Inc
$18.83 from Eisai Inc.
$16.60 from Medtronic MiniMed, Inc.
$13.63 from AKRIMAX PHARMACEUTICALS, LLC
$11.72 from Endo Pharmaceuticals Inc.
Payments received by Dr. David Sneid, MD were from the following categories:
$2,430.00 Consulting Fee
$1,106.45 Food and Beverage
$379.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!